Digital Chinese Medicine
Издатель: Elsevier · ISSN 2589-3777 · 58 статей
-
Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations
Publication date: Available online 19 September 2026 Source: Cytotherapy Author(s): Natalia O. Ivanova, Anna I. Serdyuk, Ekaterina I. Fefelova, Arseniy E. Yuzhalin, Apollinariya V. Bogolyubova
-
Interferon γ MSC accumulation in the lungs is mediated by integrin α 4 β 1 adhesion
Publication date: Available online 20 September 2026 Source: Cytotherapy Author(s): Elisabetta M. Foppiani, Andre J. Burnham, Edwin M. Horwitz
-
What Drives Investment in Cell and Gene Therapy? Evidence from a Global Investor Survey of 100 Investors
Publication date: Available online 23 September 2026 Source: Cytotherapy Author(s): Ksenia Bezverbnaya, Sandeep Mangrati, Asthika Goonewardene, Vered Gigi, Sven Kili, Patrick Rivers
-
Sustainable Point-of-Care Manufacturing of Cell and Gene Therapies: Operational, Regulatory and Economic Pathways for Implementation
Publication date: Available online 29 September 2026 Source: Cytotherapy Author(s): Folashade Otegbeye, Patrick J. Hanley, Emily L. Hopewell, Bambi J. Grilley, Olive Sturtevant, Joanne Kurtzberg, Rob Tressler
-
Drug or Medical Technology? China’s Dual-Track Regulation of Cell and Gene Therapy under State Council Order No. 818
Publication date: Available online 1 October 2026 Source: Cytotherapy Author(s): Lu Xu, Xinbao Hao
-
Safety, efficacy, and PK/PD of a BCMA-targeted CAR-NK cell therapy (LUCAR-B68) in relapsed/refractory multiple myeloma: a phase I study
Publication date: Available online 2 October 2026 Source: Cytotherapy Author(s): Shan Meng, Fangxia Wang, Ying Shen, Yang Zhang, Xuehong Ma, Aili He, Wanhong Zhao
-
Clinical trials with Advanced Therapy Medicinal Products in Europe (2016–2025): the Regulators’ analysis
Publication date: Available online 8 October 2026 Source: Cytotherapy Author(s): Ilona G Reischl-Kok, Toine Egberts, Olga Kholmanskikh, Rozalina Kulaksazova, Denisa Marilena Margina, Dariusz Sladowski, Stefan Strasser, Giovanni...
-
Significant Differences in Infrastructure, Financing, and Workforce exist across Cell Therapy Manufacturing Facilities. A Report from BEST Collaborative.
Publication date: Available online 8 October 2026 Source: Cytotherapy Author(s): Beth Shaz, Deven Gupta, Anh Dinh, Joseph Schwartz, Suzanne Thibodeau, Magali Fontaine, Biomedical Excellence for Safer Transfusion (BEST) Collaborative
-
Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region
Publication date: Available online 15 October 2026 Source: Cytotherapy Author(s): Zeyan Shi, Xing Chen, Yue Chun, Fankai Meng, Yang Cao, Zhicheng Zhang, Zhenfang Liu, Wang Wei, Xiaojian Zhu
-
A call to action: Position papers from the FDA Cell Therapy Liaison Meeting (CTLM) Working Group
Publication date: Available online 15 October 2026 Source: Cytotherapy Author(s): Olive Sturtevant, Christina M. Celluzzi, Fajar Dumadi, Patrick Hanley
-
Cytokine-Independent Proliferation of CAR-T cells: Bug or Feature?
Publication date: Available online 15 October 2026 Source: Cytotherapy Author(s): Peirong Hu, Louisa Wirthlin, Alun Carter, Jonathan Dinsmore, Bernd Schoeder, Stefan Miltenyi, Juergen Schmitz, Mario Assenmacher, Boris Engels, Pradyot...
-
The Commercial Viability of Cell Therapy: We Cannot Continue to Accept the Status Quo
Publication date: Available online 21 October 2026 Source: Cytotherapy Author(s): Thomas R J Heathman, Keara Trinkle
-
Practical Guide for Bench-to-Bedside Translation of Adoptive Cell Therapies: A Case-Based Series
Publication date: Available online 23 October 2026 Source: Cytotherapy Author(s): Jasia Mahdi, Jay Tanna, Piriya Yoganathan, Christopher Chien, Michelle Monje, Steven Highfill, Patrick J. Hanley, Catherine M. Bollard, Fahmida Hoq, Naomi...
-
The Spanish Approach to Supporting the Development of SoHO Preparations, ATMPs, and Other SoHO-Based Products Under the New EU Regulation
Publication date: Available online 23 October 2026 Source: Cytotherapy Author(s): Natividad Cuende, Dolores Hernández, Rebeca Sánchez, Ruth Barrio, Beatriz Domínguez-Gil, Antonia José Alvarez Márquez, Marina Álvarez, Belén Alvarez...
-
Optimization of a serum-free and stroma-free induction system for large-scale generation of functional red blood cells from human hematopoietic stem cells
Publication date: Available online 24 October 2026 Source: Cytotherapy Author(s): Zhe-Young Lin, Yun Chen, Cheng-Hao Wen, Chang-Hsun Tsai, Yu-Jen Chang, Yu-Tzu Tsao, Wei-Lun Huang, Chieh-Tsung Lo, Yi-Fang Tu, Po-Ming Wu, Chao-Ling Yao
-
Key Considerations for In Vitro Assessment of On- and Off-target/ Off-Disease Effects of Chimeric Antigen Receptor T-Cell Therapies
Publication date: Available online 27 October 2026 Source: Cytotherapy Author(s): Shari A. Price, Alberto del Rio, George Papadapolous, Jonathan M. Clingan, Yi Yang, Louise Brackenbury, Sara Compte Sancerni, David Cobeta Lopez, Sabrina...
-
Functional assessment reveals the properties of ABCG2-positive limbal stem cells derived from human pluripotent stem cells
Publication date: Available online 28 October 2026 Source: Cytotherapy Author(s): Tanja Ilmarinen, Gary Hin-Fai Yam, Meri Vattulainen, Jos Smits, Moira L Geary, Ella J Dewald, Taina Viheriälä, Huiqing Zhou, Vishal Jhanji, Heli Skottman
-
Cord blood regulatory T cells outperform adult and thymus Tregs in therapeutic potential for next-generation cell therapy
Publication date: Available online 29 October 2026 Source: Cytotherapy Author(s): Samikshya Santosh Nirmala, Kavitha Lakshmi, Yueyuan Hu, Liliana R. Loureiro, Anja Feldmann, Marcel Vollroth, Alexander Platz, Anke Fuchs
-
Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
Publication date: Available online 29 October 2026 Source: Cytotherapy Author(s): Jun Liu, Shin-Young Park, Hirotomo Nakahara, Yembur Ahmad, Ziyang Shen, Suhayla Sarhan, Stephanie Ferrara, Vanessa Anjurthe, Kristi Georgilas, Sarah...
-
In vitro and in vivo antibacterial activity of the mesenchymal stem cell secretome against Escherichia coli colonization among infants
Publication date: Available online 31 October 2026 Source: Cytotherapy Author(s): Aynaa Al-Khatib, Elie Salem Sokhn, Charbel Khalil, Fatima A. Saleh
-
Establishment and multisite evaluation of a MOLT-4 cell-based IL-2-independent growth assay to detect transformed cells in T-cell products
Publication date: Available online 3 November 2026 Source: Cytotherapy Author(s): Shinji Kusakawa, Nozomi Takada, Hatsue Furukawa, Mayumi Futamura, Shinko Hata, Takeshi Watanabe, Megumi Takano, Takumi Miura, Rumi Sawada, Yoshimi...
-
iPSC-derived engineered immune cells: a therapeutic platform
Publication date: Available online 5 November 2026 Source: Cytotherapy Author(s): Laetitia Pinte, Jeynina Kanapathipillai, Jimmy Lagarde, Laurence Daheron, Helene Negre, Jerome Ritz
-
Compassionate and Emergency Use Cellular Therapy Products: Regulatory, Operational, and Quality Considerations
Publication date: Available online 7 November 2026 Source: Cytotherapy Author(s): Garrett S. Booth, Ron Ram, Jeremy W. Jacobs, Bipin N. Savani, Eric A. Gehrie, Joseph (Yossi) Schwartz, Yvette C. Tanhehco
-
Rapid epigenetic analysis for quantification of iPSC pluripotency from dried cell spots
Publication date: Available online 9 November 2026 Source: Cytotherapy Author(s): Kira Zeevaert, Vera Nischalke, Tobias Schlangen, Wolfgang Wagner
-
NIVOLUMAB-CONTAINING SALVAGE CHEMOTHERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA MAY IMPAIR STEM CELL MOBILIZATION
Publication date: Available online 11 November 2026 Source: Cytotherapy Author(s): Maria K Angelopoulou, Athanasios Liaskas, Eleni Lalou, Aikaterini Benekou, Eleni Siavou, Alexandros Machairas, Aikaterini Kolotsiou, Eliana Konstantinou,...
-
A Genetically Engineered, Monoclonal, and Inducible Mesenchymal Stem Cell Platform with Controlled Proliferation and In Vivo Traceability
Publication date: Available online 12 November 2026 Source: Cytotherapy Author(s): Mohammad Massumi, Hajar Owji, Ge Yang, Arash Hatefi
-
Enhancing NK cell cytotoxicity with innate cell engagers as an alternative to CAR-NK cells
Publication date: Available online 12 November 2026 Source: Cytotherapy Author(s): Ioana Sonya Ciulean, Julia Uhlig, Thea Eichenberg, Joe Fischer, Michael Albers, Christian Breunig, Jan C. Schmollinger, Ivica Fucek, Nadine Heimer, Paul...
-
Long-term 3D tumor spheroid cultures enable evaluation of durable effector T cell function in solid tumors
Publication date: Available online 13 November 2026 Source: Cytotherapy Author(s): Alejandro G. Torres Chavez, Ayumi Watanabe, Dan Welch, Andrew Scheffler, Ann M. Leen, Mary K. McKenna
-
IMPACT OF RUXOLITINIB ON VIRUS SPECIFIC-T LYMPHOCYTES: AN IN VITRO STUDY
Publication date: Available online 14 November 2026 Source: Cytotherapy Author(s): José-Arthur Guimaraes, Mélanie Gauthier, Fanny Vreken, Jessica Morello, Jean-Hugues Dalle, Loïc Reppel, Danièle Bensoussan
-
Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions
Publication date: Available online 17 November 2026 Source: Cytotherapy Author(s): Kunihiko Suzuki, Yasunobu Takagi, Daisuke Akahane, Satoshi Kouhata, Hideo Jinguji, Makiko Kunisawa, Mitsuko Mochizuki, Keisuke Sato, Daisuke Noguchi,...